Associations of cortical astrogliosis with cognitive performance and dementia status

Journal of Alzheimer's Disease

Volumn 6, Issue 6, 2004, Pages 595-604

  Kashon, Michael L ^a   Ross, G Webster ^b,c,d,e   O'Callaghan, James P ^a   Miller, Diane B ^a   Petrovitch, Helen ^b,c,d,e   Burchfiel, Cecil M ^a   Sharp, Dan S ^a   Markesbery, William R ^f   Davis, Daron G ^f   Hardman, John ^c   Nelson, James ^d,e   White, Lon R ^b,c,d,e  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^e KUAKINI MEDICAL CENTER   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; astrogliosis; cognitive performance; dementia; GFAP; neurofibrillary tangle; neurotic plaque

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 19944431195     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2004-6604     Document Type: Article

References (63)

1. D. Aarsland, C. Ballard, J.P. Larsen and I. McKeith, A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia, Int. J. Geriatr. Psychiatry 16 (2001), 528-536.
2. K.T. Akama and L.J. Van Eldik, β-Amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκB-inducing kinase-dependent signalling mechanism, J. Biol. Chem. 275 (2000), 7918-7924.
3. H. Akiyama, S.Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S.Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk and T. Wyss-Coray, Inflammation and Alzheimer's disease, Neurobiol. Aging 21 (2000), 383-421.
4. T. Arendt, Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization, Neuroscience (2001), 723-765.
5. S.E. Arnold, L.Y. Han, C.M. Clark, M. Grossman and J.Q. Trojanowski, Quantitative neurohistological features of frontotemporal degeneration, Neurobiol Aging 21 (2000), 913-919.
6. P.V. Arriagada, K. Marzloff and B.T. Hyman, Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42 (1992), 1681-1688.
7. C.D. Balaban, J.P. O'Callaghan and M.L. Billingsley, Trimethyl-tin- induced neuronal damage in the rat brain: Comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins, Neuroscience 26 (1988), 337-361.
8. T.G. Beach and E.G. McGeer, Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex, Brain Res 463 (1988), 357-361.
9. L. Berg, Mild senile dementia of the Alzheimer's type: diagnostic criteria and natural history, Mt. Sinai J. Med. 55 (1988), 87-96.
10. T.O. Brock and J.R O'Callaghan, Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system, J. Neurosci. 7 (1987), 931-942.
11. H.C. Chui, J.I. Victoroff, D. Margolin, W. Jagust, R. Shankle and R. Katzman, Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers, Neurology 42 (1992), 473-480.
12. H. Crystal, D. Dickson, P. Fuld, D. Masur, R. Scott, M. Mehler, J. Masdeu, C. Kawas, M. Aronson and L. Wolfson, Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease, Neurology 38 (1988), 1682-1687.
13. J.L. Cummings and D.E. Benson, Dementia: A Clinical Approach, 2nd ed. Boston: Butterworths-Heinemann Medical, 1992.
14. D.G. Davis, F.A. Schmitt, D.R. Wekstein and W.R. Markesbery, Alzheimer neuropathologic alterations in aged cognitively normal subjects, J. Neuropathol. Exp. Neurol. 58 (1999), 376-388.
15. A. Delacourte, General and dramatic glial reaction in Alzheimer brains, Neurology 40 (1990), 33-37.
16. J.C. de la Torre and G.B. Stefano, Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide, Brain Res. Rev. 34 (2000), 119-136.
17. L.F. Eng, Glial fibrillary acidic protein (GEAR): the major protein of glial intermediate filaments in differentiated astrocytes, J. Neuroimmunol. 8 (1985), 203-214.
18. L.F. Eng, R.S. Ghirnikar and Y.L. Lee, Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000), Neurochem. Res. 25 (2000), 1439-1451.
19. D.A. Evans, H.H. Funkenstein, M.S. Albert, P.A. Scherr, N.R. Cook, M.J. Chown, L.E. Hebert, C.H. Hennekens and J.O. Taylor, Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported, JAMA 262 (1989), 2551-2556.
20. J.W. Geddes, T.L. Tekirian, N.S. Soultanian, J.W. Ashford, D.G. Davis and W.R. Markesbery, Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease, Neurobiol. Aging 18 (1997), S99-S105.
21. D.S. Geldmacher and P.J. Whitehouse, Evaluation of dementia, N. Engl. J. Med. 335 (1996), 330-336.
22. M.L. Harpin, P. Delaere, F. Javoy-Agid, E. Bock, C. Jacque and B. Delpech, Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles, J. Neurosci. Res. 27 (1990), 587-594.
23. M.E. Hatten, R.K. Liem, M.L. Shelanski and C.A. Mason, Astroglia in CNS injury, Glia 4 (1991), 233-243.
24. J. Joseph, B. Shukitt-Hale, N.A. Denisova, A. Martin, G. Perry and M.A. Smith, Copernicus revisited: amyloid beta in Alzheimer's disease, Neurobiol. Aging 22 (2001), 131-146.
25. A. Kagan, The Honolulu Heart Program: An epidemiological study of coronary heart disease and stroke, Amsterdam: Hardwood Academic Publishers, 1996.
26. Z.S. Khachaturian, Diagnosis of Alzheimer's disease, Arch. Neurol. 42 (1985), 1097-1105.
27. D.S. Knopman, An overview of common non-Alzheimer dementias, Clin. Geriatr. Med. 17 (2001), 281-301.
28. A.R. Little, S.A. Benkovic, D.B. Miller and J.P. O'Callaghan, Chemically-induced neuronal damage and gliosis: Enhanced expression of the proinflammatory cytokine, MCP-1, without a corresponding increase in proinflammatory cytokines, Neuroscience 115 (2002), 307-320.
29. J. Llorens, K.M. Crofton and J.P. O'Callaghan, Administration of 3,3′-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem, J. Pharmacol. Exp. Ther. 265 (1993), 1492-1498.
30. L.F. Lue, L. Brachova, W.H. Civin and J. Rogers, Inflammation, Aβ deposition and neurofibrillary tangle formation correlates of Alzheimer's disease neurodegeneration, J. Neuropathol. Exp. Neurol. (1996), 1083-1088.
31. P.M. Martin and J.P. O'Callaghan, A direct comparison of GFAP immunocytochemistry and GFAP concentration in various regions of ethanol-fixed rat and mouse brain, J. Neurosci. Methods 58 (1995), 181-192.
32. E. Masliah and F. Licastro, Neuronal and synaptic loss, reactive gliosis, microglial response, and induction of the complement cascade in Alzheimer's disease, in: Neurodegenerative Dementias, C.M. Clarke and J.Q. Trojanowski, eds, McGraw-Hill, New York, 2000, pp. 131-146.
33. P. McGeer and E.G. McGeer, The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Res. Rev. (1995), 195-218.
34. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
35. S.S. Mirra, M.N. Hart and R.D. Terry, Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists, Arch. Pathol. Lab Med. 117 (1993), 132-144.
36. T. Miyake, T. Hattori, M. Fukuda, T. Kitamura and S. Fujita, Quantitative studies on proliferative changes of reactive astrocytes in mouse cerebral cortex, Brain Res 451 (1988), 133-138.
37. D.G. Morgan, C.E. Finch and S.A. Johnson, RNA metabolism in Alzheimer's disease: selective increase in GFAP RNA, in: Alzheimer 's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, K. Iqbal, D.R.C. Mclachlan, B. Winblad and H.M. Wisniewski, eds, John Wiley & Sons, Ltd., New York 1999, pp. 407-416.
38. J.C. Morris, A. Heyman, R.C. Mohs, J.P. Hughes, G. van Belle, G. Fillenbaum, E.D. Mellits and C. Clark, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease, Neurology 39 (1989), 1159-1165.
39. 1-42 in wild-type human amyloid precursor transgenic mice: synaptotoxicity with plaque formation, J. Neurosci. 20 (2000), 4050-4058.
40. W.T. Norton, D.A. Aquino, I. Hozumi, F.C. Chiu and C.F. Brosnan, Quantitative aspects of reactive gliosis: a review, Neurochem. Res. 17 (1992), 877-885.
41. J.P. O'Callaghan, Quantification of glial fibrillary acidic protein: comparison of slot- immunobinding assays with a novel sandwich ELISA, Neurotoxicol. Teratol. 13 (1991), 275-281.
42. J.P. O'Callaghan, Quantitative features of reactive gliosis following toxicant-induced damage of the CNS, Ann. N Y Acad. Sci. 679 (1993), 195-210.
43. J.P. O'Callaghan, Measurement of glial fibrillary acidic protein, in: Current Protocols In Toxicology, L.G. Costa, ed., John Wiley & Sons, New York, 2002, pp. 12.81.1-12.8.12.
44. J.P. O'Callaghan, K.F. Jensen and D.B. Miller, Quantiatitve aspects of drug and toxicant-induced astrogliosis, Neurochem. Int. 26 (1995), 115-124.
45. J.P. O'Callaghan and D.B. Miller, The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain, Neurobiol. Aging 12 (1991), 171-174.
46. J.P. O'Callaghan and D.B. Miller, Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse, J. Pharmacol. Exp. Ther. 270 (1994), 741-751.
47. J.P. O'Callaghan, D.B. Miller and J.F. Reinhard Jr., Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Brain Res 521 (1990), 73-80.
48. J.J. Palop, B. Jones, L. Kekonius, J. Chin, G.-Q. Yu, J. Raber, E. Masliah and L. Mucke, Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits, Proc. Natl. Acad. Sci. USA 100 (2003), 9572-9577.
49. H. Petrovitch, J. Nelson, D. Snowdon, D.G. Davis, G.W. Ross, C.Y. Li and L. White, Microscope field size and the neuropathologic criteria for Alzheimer's disease, Neurology 49 (1997), 1175-1176.
50. H. Petrovitch, L.R. White, G.W. Ross, S.C. Steinhorn, C.Y. Li, K.H. Masaki, D.G. Davis, J. Nelson, J. Hardman, J.D. Curb, P.L. Blanchette, L.J. Launer, K. Yano and W.R. Markesbery, Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study, Neurology 57 (2001), 226-234.
51. J.L. Price and J.C. Morris, Tangles and plaques in nondemented aging and preclinical Alzheimer's disease, Ann. Neurol. 45 (1999), 358-368.
52. G.W. Ross, J.P. O'Callaghan, D.S. Sharp, H. Petrovitch, D.B. Miller, R.D. Abbott, J. Nelson, L.J. Launer, D.J. Foley, C.M. Burchfiel, J. Hardman and L.R. White, Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease, Acta Neurol Scand 107(5) (May, 2003), 318-323.
53. K. Sriram, S.A. Benkovik, H. Ma, D.B. Miller and J.P. O'-Callaghan, Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fivrillary acidic protein in the 1-methyl-4-prhenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signalling pathway for astrogliosis in vivo? J. Biol. Chem. 279 (2004), 19936-19947.
54. S.L. Syme, M.G. Marmot, A. Kagan, H. Kato and G. Rhoads, Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction. Am. J. Epidemiol. 102 (1975), 477-480.
55. C.I. Sze, J.C. Troncoso, C. Kawas, P. Mouton, D.L. Price and L.J. Martin, Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease, J. Neuropathol. Exp. Neurol. 56 (1997), 933-944.
56. Y. Takamiya, S. Kohsaka, S. Toya, M. Otani and Y. Tsukada, Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats, Brain Res 466 (1988), 201-210.
57. E.L. Teng, K. Hasegawa, A. Homma, Y. Imai, E. Larson, A. Graves, K. Sugimoto, T. Yamaguchi, H. Sasaki, D. Chiu and L.R. White, The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia, Int. Psychogeriatr. 6 (1994), 45-58.
58. B. Van Everbroeck, E. Dewulf, P. Pals, U. Lubke, J.J. Martin and P. Cras, The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease, Neurobiol. Aging 23 (2002), 59-64.
59. K. Welsh, N. Butters, J. Hughes, R. Mohs and A. Heyman, Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures, Arch. Neurol. 48 (1991), 278-281.
60. L. White, K. Masaki, G.W. Ross, H. Petrovitch, D. Chiu and E. Teng, Estimation of the sensitivity and specificity of a dementia screening test in a population-based survey, Neurobiol. Aging 15 (1994), 171.
61. L. White, H. Petrovitch, J. Hardman, J. Nelson, D.G. Davis, G.W. Ross, K. Masaki, L. Launer and W.R. Markesbery, Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants, Ann. N. YU. Acad. Sci. 977 (2002), 9-23.
62. L. White, H. Petrovitch, G.W. Ross, K.H. Masaki, R.D. Abbott, E.L. Teng, B.L. Rodriguez, P.L. Blanchette, R.J. Havlik, G. Wergowske, D. Chiu, D.J. Foley, C. Murdaugh and J.D. Curb, Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study, JAMA 276 (1996), 955-960.
63. R.M. Worth and A. Kagan, Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration, J. Chronic Dis. 23 (1970), 389-397.